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potential for ischemia and seizure.1)5) AVM has an annual 
hemorrhage rate of 2-3% that persists as long as the lesion 
exists.1)3)5) Management of these lesions can be observation-
al, although lesion obliteration is typically considered to miti-
gate these risks.1)
Over the last decades, the management options for arterio-
venous malformations (AVM) have expanded.2) Although 
microsurgical resection has been used as the primary treat-
ment option, stereotactic radiosurgery and embolization have 
been established as effective treatment options for AVM.2)5)10) 
Moreover, recent advances in imaging technology and com-
puterized radiation dose planning have improved the out-
comes of radiosurgery.2) Gamma knife radiosurgery (GKRS) 
has emerged as a popular treatment tool for AVMs without 
the immediate risk of hemorrhage.23) GKRS is widely used 
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Objective: We retrospectively evaluated our experience of the management and long-term outcomes of gamma knife radiosur-
gery (GKRS) on arteriovenous malformation (AVM) as a primary treatment as well as adjunct therapy. GKRS is widely used in 
many centers worldwide for the management of AVM. However, the long-term results of GKRS are not well known. In the pres-
ent study, we retrospectively evaluated our experience of focusing on prognostic factors in the management and long-term out-
comes of GKRS on AVM.
Materials and Methods: We performed a retrospective review of 218 patients. They were treated with GKRS in our institute 
from 2007 to 2013. The group included first-time GKRS for cerebral AVM, previous surgical resection, and embolization, exclud-
ing previously GKRS-treated patients. We analyzed the association between several factors (gender, age, marginal dose, hemor-
rhage, marginal dose, nidus volume) and the obliteration rate, which was the cumulative obliteration rate regardless of additional 
treatment, including repeat GKRS. 
Results: The univariate analysis of our study identified that a high radiation dose [margin dose ＞16.0Gy (50%), p=0.017] rather 
than a low radiation dose [margin dose ≤16.0Gy (50%)] and small AVM volume (≤15.0mL, p=0.003) rather than large AVM vol-
ume (＞15.0mL) were positive predictors of AVM nidus obliteration. Our study showed that young age (≤18 years) had a better 
obliteration rate compared with others (＞18 years) in AVM after GKRS (p=0.053). Our findings did not show that gender (p= 0.427) 
or hemorrhage (p=0.191) had significant effects on nidus obliteration. Comparison of our results with prior studies showed that 
AVM volume and margin radiation dose had a significant role in the obliteration rate in common.
Conclusion: We suggest that AVM with a small volume can be considered good indications for GKRS, and a higher marginal 
dose [margin dose ＞16.0Gy (50%)] can be an effective factor for higher obliteration with the carefulness of post-radiosurgical 
complications. Finally, we can expect favorable GKRS results for appropriately selected AVMs in the young population.
KEY WORDS: Arteriovenous malformation (AVM) · Gamma knife radiosurgery (GKRS) · Obliteration rate · Prognostic factors.
INTRODUCTION
Cerebral arteriovenous malformations (AVMs) are patho-
logic vascular lesions found in children and adults with a 
prevalence in adults of approximately 18 per 100,000.1) AVM 
is defined by an abnormal connection between the venous 
and arterial circulation, resulting in an arteriovenous shunt 
and the gross appearance of a tangle of blood vessels.1) The 
angioarchitecture of these lesions puts them at risk of hem-
orrhage as well as subjecting the adjacent parenchyma to the 
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in many centers worldwide for the management of AVM.2) 
GKRS is usually applied as a single treatment for small 
AVMs (＜3 cm) as well as a part of multimodal therapy in 
combination with microsurgical resection and emboliza-
tion for large AVMs.2) Evidence from the literature reveals 
that GKRS had a significant impact on the obliteration of the 
AVM nidus in 65-94% patients over a 5-year observation 
interval.2) GKRS has been associated with a low risk of ra-
diation-related complications, even for lesions located in ar-
eas that are difficult to access via microsurgery.2) However, 
little information is available regarding the intermediate or 
long-term outcomes of GKRS on AVM.2) In the present study, 
we retrospectively evaluated our experience, focusing on 
prognostic factors in the management and long-term out-
comes of GKRS on AVM.
MATERIALS AND METHODS
A total of 218 patients were treated with GKRS in our 
institute from 2007 to 2013. The group included first-time 
GKRS for cerebral AVM, previous surgical resection, and 
embolization excluding previously GKRS-treated patients. 
We analyzed the correlation between several factors (gender, 
age, marginal dose, hemorrhage, marginal dose, nidus vol-
ume) and the obliteration rate, which was the cumulative 
obliteration rate regardless of additional treatment, includ-
ing repeat GKRS. 
 
Statistical analysis
Various factors that may affect the outcome were analyzed. 
Descriptive statistics is demonstrated as mean, median, stan-
dard deviation (SD), percentages, and range. Kaplan-Meier 
method and log-rank analysis were used for actuarial rates 
of outcome and related factors. Multivariate analyses were 
performed by using a Cox regression analysis. All analyses 
were performed using commercially available statistical soft-
ware SPSS Statistics (version 21.0 ; IBM Co., Armonk, NY, 




The characteristics of the patients are listed in Table 1. Out 
of the 218 patients, 127 (58.3%) were men and 91 (41.7%) 
were women. Forty-five patients were younger than 18 years 
old at the time of GKRS. One hundred and thirteen (51.8%) 
patients had a history of prior ruptured hemorrhage. The 
AVM volume of 181 patients was ≤15.0mL, and that of 
the others was ＞16mL. The marginal dose for the AVM of 
114 (52.3%) patients was ≤16.0Gy(50%), and that of 104 
(47.7%) patients was ＞16.0Gy. 
GKRS technique and treatment planning
The Leksell Gamma Knife model C was used until Octo-
ber 2008, when the Leksell Gamma Knife Perfexion (Elekta 
Instruments, Inc.) replaced it. Treatment planning was based 
on biplane digital subtraction angiography and magnetic 
resonance imaging (MRI). The MRI protocol includes T1 
gadolinium-enhancing and T2 thin section, as well as time 
of flight (TOF) angiographic images if needed. The radio-
surgical target was defined compactly to minimize compli-
cations using both imaging modalities. We performed dose 
control at the major artery, avoiding high-dose radiation, 
which was able to reduce the chance of cerebral infarction.
Follow-up evaluation
In our studies, the AVM obliteration was confirmed by 
MRI (6 months, 2 years, 3 years), computed tomography 
angiography (CTA) (1 year), and cerebral angiography (wait-
ing up to 3 years after GKRS). If needed, repeated GKRS 
2-3 years after previous GKRS was performed. The actu-
arial obliteration rate of the AVM was calculated using the 
Kaplan-Meier curve. The median duration of follow-up was 
24.0 months (range : 6-77).




≤18 yrs 045 20.6








≤16.0Gy (50%) 114 52.3




AVM : arteriovenous malformation, GKRS : gamma knife radio-
surgery
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RESULTS
We analyzed the association between several factors, in-
cluding gender, age, hemorrhage, margin dose, and AVM 
volume, with the obliteration rate of the nidus. The results of 
AVM obliteration after GKRS are below Fig. 1. 
Following a single GKRS procedure, 152 (69.7%) of 218 
patients still had a residual nidus shown on MRI or angiog-
raphy. Additionally, 17 patients harboring residual AVMs 
underwent repeat GKRS, and a total AVM obliteration was 
identified in 5 of these patients. After all, in 71 (32.6%) pa-
tients, obliteration of the nidus was identified on follow-up 
angiography (60 patients) and MRI (11 patients). Clinical 
follow-up greater than 3 years was in 75 patients (34.4%), 
and 42 of these patients were confirmed as a total obliteration 
on both angiography and MRI. The actuarial angiographic 
or MRI obliteration rate was 10.64% at 24 months, 26.1% 
at 36 months, and 66.6% at 60 months, respectively (Fig. 1). 
Our overall obliteration rate was 32.6% through the follow-
up duration (mean 33.8±2.7 months).
 
Factors related to AVM obliteration
The results of factors related to AVM obliteration after 
GKRS are below Fig. 2. Statistical analysis demonstrated 
that a margin dose of more than 16.0Gy (50%) showed sta-
tistical significance for better AVM obliteration (Log Rank 
p=0.017).
Small nidus volume (Log Rank p=0.003) was also asso-
ciated with increased AVM obliteration. Gender (Log Rank 
p=0.427) and hemorrhage (Log Rank p=0.191) were not re-
lated to nidus obliteration. In our study, a younger age (Log 
Rank p=0.053) showed some association with AVM oblit-
eration.
Statistical analysis demonstrated that gender (Log Rank 
p=0.427) was not related to AVM obliteration. Age (Log 
Rank p=0.053) was relatively associated with AVM obliter-
ation. The mean time for obliteration was 41.1±3.6 months 
at ≤18 years and 49.7±2.3 months at ＞18 years. The 
younger group showed a shorter obliteration time. The 
mean time for the obliteration of ruptured AVM was 44.7±
3.1 months, and that of unruptured AVM was 50.4±2.6 
months. Hemorrhage (Log Rank p=0.191) was not related 
to nidus obliteration. Our study showed that a high median 
marginal dose [＞16.0Gy (50%)] rather than a low median 
marginal dose [≤16.0Gy (50%)] was significantly associ-
ated with an increased rate of AVM obliteration (Log Rank 
p=0.017). The group with the ＞16.0Gy (50%) marginal 
dose had a shorter obliteration time (41.5±2.8 months) than 
the one with ≤16.0Gy (50%) (51.7±2.6 months). Small 
volume (≤15.0mL) rather than large volume (＞15.0mL) 
revealed a significant statistical difference of AVM obliter-
ation (Log Rank p=0.003). The mean time for the oblitera-
tion of small volume (≤15.0mL) was 44.4±2.2 months, 
and that of large volume (＞15.0mL) was 59.1±3.3 months. 
In multivariate analysis, only small nidus volume (p=0.045) 
was significantly associated with increased rate of AVM 
obliteration (Table 2).
 
Complication associated with treatment
Overall, a post-GKRS complication was recorded for 40 
patients (18.3%). Posttreatment hemorrhage occurred in 12 
patients (5.5%), 1 of whom was brain death after emergen-
cy hematoma removal. Eight (3.7%) patients developed 
brain edema and seven (3.2%) patients developed GKRS 
related cyst formation. One of 7 patients having brain cyst 
underwent Ommaya reservoir insertion. Four (1.8%) patient 
had newly developed post-GKRS seizures and two (0.9%) 
had preexisting seizures. Hydrocephalus, paresthesia on 
limbs, memory impairment, radiation necrosis, character 
change, and cerebral infarction were developed in each one 
(0.5%) patient. The patient with hydrocephalus recovered 
his heath after a ventriculoperitoneal shunt. In addition to 
being mentioned, there were not in life-threatening conditions. 
Most of them had responded to conservative treatment. 
Fig. 1. Kaplan-Meier plot depicting the AVM obliteration rates fol-
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DISCUSSION
AVM radiosurgery is a well-established strategy for AVMs. 
Despite the risk of post-radiolosurgical complications, in-
cluding the risk of a latency-interval hemorrhage, delayed 
cyst formation, and radiation-induced normal brain tissue 
damage.22) GKRS is considered an effective, safe, and min-
imally invasive treatment option for AVM obliteration. How-
ever, the risk-benefit profile of GKRS on AVM is not well 
understood. Here, we retrospectively evaluated our experi-
ence of the long-term outcomes of GKRS on AVM, includ-
ing obliteration of the nidus after GKRS and prognostic fac-
tors affecting the outcomes in patients with AVM. GKRS 
on AVM has a protective effect against the risk of future 
hemorrhage and helps the majority of AVM patients con-
tinue their normal daily activities. The obliteration of the AVM 
nidus and absence of any signs or symptoms are the treat-
ment goals of GKRS for AVM. Many studies on GKRS for 
AVM suggest that the obliteration rate is 65-94%.16,17,20 
This obliteration can be accomplished within 2-3 years with 
some exceptions, where it may require 3-5 years to obliter-
ate the nidus.7) 
Yen, et al. showed various factors related to nidus oblitera-
tion, such as female gender, age, pre-GKRS embolization, 
Fig. 2. Kaplan-Meier plot demonstrating the obliteration rates of the patient population throughout the follow-up period (months). (A) Gen-
der (the mean time for obliteration was 49.2±2.9 months at male and 45.8±2.8 months at female) (B) age (the mean time for oblitera-
tion was 41.1±3.6 months at ≤18 years and 49.7±2.3 months at ＞18 years) (C) hemorrhage (the mean time for obliteration was 44.7±
3.1 at ruptured cases and 50.4±2.6 at unruptured cases) (D) margin dose [the mean time for obliteration was 51.7±2.6 at ≤16.0Gy (50%) 
and 41.5±2.8 at ＞16.0Gy (50%)] (E) volume [the mean time for the obliteration was 44.4±2.2 months at small volume (≤15.0mL) and 
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AVM volume, location, deep-draining vein, single-draining 
vein, margin dose, maximum dose, isodense line, isocenters, 
radiation-induced changes, and radiosurgery-based AVM 
score.23) Their univariate analysis demonstrated that high 
margin dose (p=0.042), high maximum dose (p=0.035), deep-
drain vein (p=0.042), and small nidus volume (p=0.015) were 
associated with increased AVM obliteration rate. Sex, age, 
prior embolization, locations of nidi, radiosurgery-based AVM 
scores, single-draining vein, isodose line, number of isocen-
ters, and presence of radiation-induced imaging changes 
were not related to nidus obliteration.23) Bir, et al. identified 
female sex (p=0.04) and Spetzler-Martin Grade I-III (p= 
0.002) as positive predictors of AVM nidus obliteration, but 
history of hemorrhage and history of embolization did not 
affect nidus obliteration. Some studies said that nidus vol-
ume is a critical factor that impedes the complete oblitera-
tion of AVMs.13)15) The lowest dose delivered to the AVM is 
an important factor related to the obliteration rate.13) It is rel-
atively easy to deliver an insufficient radiation dose to the 
nidus of a large AVM, and the operator wants to avoid ad-
verse radiation effects (ARE).14)15) The above studies showed 
that AVM nidus volume and radiation dose had the effect on 
nidus obliteration in common. 
In this study, we had an interest in the young age effect on 
the AVM obliteration rate as a prognostic factor. The opti-
mal management of unruptured AVMs in pediatric patients 
is now incompletely understood.9) A Randomized Trial of 
Unruptured Brain AVMs (ARUBA) was a prospective, ran-
domized controlled trial that showed superior outcomes 
with medical management compared with intervention for 
patients with unruptured AVMs.18) However, pediatric pa-
tients (aged less than 18 years) were specifically excluded 
from ARUBA. Therefore, the efficacy of radiosurgery for 
unruptured pediatric AVMs is poorly understood.9) From 
our review of the major series, the reported obliteration rates 
derived from retrospective studies of pediatric patients vary 
widely, ranging from 45% to 84% in studies reporting 3-year 
radiographic outcomes.4)6)8)11)12)19)21)24)25)
We evaluated several factors, gender, age, hemorrhage, 
margin dose, and AVM volume, with the obliteration rate of 
the nidus. The univariate analysis of our study identified that 
a high radiation dose (margin dose ＞16.0Gy (50%), p=0.017) 
rather than a low radiation dose [margin dose ≤16.0Gy 
(50%)] and small AVM volume (≤15.0mL, p=0.003) rather 
than large AVM volume (＞15.0mL) were positive predic-
tors of AVM nidus obliteration. Our study showed that young 
age (≤18 years) had a better obliteration rate compared with 
others (＞18 years) in AVM after GKRS (p=0.053). Our 
findings did not show that gender (p=0.427) or hemorrhage 
(p=0.191) had significant effects on nidus obliteration. 
Comparison of our results with prior studies showed that 
AVM volume and margin radiation dose had a significant 
role in the obliteration rate in common. However, the age 
effect as a prognostic factor is not well defined. Yen, et al.23) 
and Bir, et al.2) showed that age was not related to nidus oblit-
eration (Table 3). Previous studies reported a lower obliter-
ation rate for GKRS in young-age AVM because the young 
Table 2. Prognostic factors for obliteration of nidus
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Yen et al.,23) 2014 031 0.015 0.619 0.778 NR ＜0.042
Borcek et al.,3) 2014 058 0.018 0.584 0.049 0.049 NR
Bir et al.,2) 2015 085 NR NR 0.040 0.240 NR
Ding et al.,9) 2015 051 0.001 NR NR NR ＜0.0001
Present study, 2015 218 0.003 0.053 0.427 0.191 ＜0.017
NR : not reported, Values that appear in boldface are statistically significant at p＜0.05 
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ages had a more aggressive flow-dynamic tendency and 
more diffuse nidus anatomy than old ages. On the other 
hand, our study showed that young age (≤18 years) tended 
to have a better obliteration rate (p=0.053).
To explain this, we consider the possibility that our study 
could have selection bias. Nonetheless, this result suggests 
that GKRS can provide an effective management option for 
appropriately selected AVMs in the young population.
The limitations of this study include its retrospective nature 
and the lack of a control group, which confines us in assess-
ing the full benefits and complications of GKRS.
 
CONCLUSION
Although surgical resection is known to be the gold stan-
dard for the treatment of AVM, GKRS for AVM is also a 
well-established treatment option with an obliteration rate 
of approximately 70-80% if surgical resection is not feasi-
ble. In our study, the overall obliteration rate increased in 
AVMs with small volumes (≤15.0mL), higher marginal dose 
(margin dose ＞16.0Gy (50%)), and young age (≤18 years). 
The obliteration rates were 10.6% at 24 months, 26.1% at 
36 months, and 66.6% at 60 months, respectively.
We suggest that AVM with a small volume can be consid-
ered good indications for GKRS, and a higher marginal dose 
(margin dose ＞16.0Gy (50%)) can be an effective factor for 
relative higher obliteration with the carefulness of post-radio-
surgical complications. 
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